Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck & Co.
Biotech
Merck pens $300M-per-drug collab to find hidden tumor antigens
Merck & Co. has penned a $300 million biobucks-per-product deal to identify previously secret antigens for off-the-shelf cancer immunotherapies.
James Waldron
Feb 19, 2025 7:00am
2024's top 10 clinical trial flops
Feb 18, 2025 3:00am
Kineta sells Genentech, Merck deals to investor ahead of merger
Feb 10, 2025 7:45am
FDA pulls diversity guidance for clinical trials from website
Jan 27, 2025 11:00am
N-Power links with Syapse, adds oncologists to research network
Jan 14, 2025 1:33pm
Merck pays $112M upfront for Hansoh's preclinical GLP-1
Dec 18, 2024 7:44am
